Abhishek Ghara

Mr. Abhishek Ghara

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
GMGurubasavaraj Swamy Purawarga Matada
Gurubasavaraj Swamy Purawarga Matada
PDPrasad Sanjay Dhiwar
Prasad Sanjay Dhiwar
NANahid Abbas
Nahid Abbas
ESEkta Singh
Ekta Singh
AGAbhishek Ghara
Abhishek Ghara
SBSapna Vyas Bhargava
Sapna Vyas Bhargava
Breast cancer (BC) is a second common malignancy in female globally. Hence, identification of novel therapeutic agents is extremely important. Molecular docking and MD simulation are the important tools in the process of drug discovery for searching the potential hits. The structure-based drug designing technique also reveals the information about ligands behavior in computational environment. Docking tools help in visualization and analysis of protein–ligand complex at atomic level. Molecular dynamics shows the stability of the molecules in the receptor cavity in the simulated environment. In this research work, we have screened potent phytochemicals against the BC. We docked the phytochemicals and examined the binding affinities of ligands towards the EGFR, HER2, estrogen and NF-κB receptors. Pristimerin, ixocarpalactone A, viscosalactone B and zhankuic acid A have shown higher binding affinities and energies towards targeted receptors among the screened phytochemicals. MD simulation study shows stability of docked complex for pristimerin and HER2 receptor. These phytochemicals can be repurposed for their anticancer activity. This in-silico work provides a strong ground for further investigation of their anticancer activity. Graphical Abstract Communicated by Ramaswamy H. Sarma

9 May 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
PDPrasad Sanjay Dhiwar
Prasad Sanjay Dhiwar
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada
RPROHIT PAL
ROHIT PAL
ESEkta Singh
Ekta Singh
AGAbhishek Ghara
Abhishek Ghara
GAGanesh Andhale
Ganesh Andhale
Epidermal growth factor receptor (EGFR) and its subtype human epidermal growth factor receptor 2 (HER2) gets activated when its endogenous ligand(s) bind to its ATP binding site of target receptors. In breast cancer (BC), EGFR and HER2 are two proteins are overexpressed which leads to overexpression of cells proliferation and decreases cell death/apoptosis. Pyrimidine is one of the most widely studied heterocyclic scaffolds for EGFR as well as HER2 inhibition. We gather some remarkable results for fused-pyrimidine derivatives on various cancerous cell lines (in-vitro) and animal (in-vivo) evaluation to highlight their potency. The heterocyclic (five, six-membered, etc.) moieties which are coupled with pyrimidine moiety are potent against EGFR and HER2 inhibitions. Hence structure-activity relationship (SAR) plays important role in study of heterocyclic moiety along pyrimidine and effects of substituents, groups for increase or decrease in the cancerous activity and toxicity. By thoughtful of fused pyrimidines SAR study, it facilitates in receiving excellent overview of the compounds by concerning of efficacy and potential summary for future EGFR inhibitors. Furthermore, we studied the in-silico interactions of synthesized compounds to evaluate binding affinity towards the key amino acids.. Communicated by Ramaswamy H. Sarma

20 July 2023 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
LMLalmohan Maji
Lalmohan Maji
GTGhanshyam Teli
Ghanshyam Teli
NRNulgumnalli Manjunathaiah Raghavendra
Nulgumnalli Manjunathaiah Raghavendra
SSSindhuja Sengupta
Sindhuja Sengupta
RPROHIT PAL
ROHIT PAL
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada

9 August 2021 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
ESEkta Singh
Ekta Singh
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada
NANahid Abbas
Nahid Abbas
PDPrasad Sanjay Dhiwar
Prasad Sanjay Dhiwar
AGAbhishek Ghara
Abhishek Ghara
ADArka Das
Arka Das

5 February 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
GMGurubasavaraja Swamy Purwarga Matada
Gurubasavaraja Swamy Purwarga Matada
PDPrasad Sanjay Dhiwar
Prasad Sanjay Dhiwar
NANahid Abbas
Nahid Abbas
ESEkta Singh
Ekta Singh
AGAbhishek Ghara
Abhishek Ghara
NRNulgumnalli Manjunathaiah Raghavendra
Nulgumnalli Manjunathaiah Raghavendra

10 October 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AGAbhishek Ghara
Abhishek Ghara
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada
PPPayel Pramanick
Payel Pramanick
USUday Raj Sharma
Uday Raj Sharma
BMBasavaraj Metikurki
Basavaraj Metikurki
PDPrasad Sanjay Dhiwar
Prasad Sanjay Dhiwar